- Home
- CDTX vs DOLE Comparison
CDTX vs DOLE Comparison
Compare CDTX & DOLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- DOLE
- Stock Information
- Founded
- CDTX 2012
- DOLE 1851
- Country
- CDTX United States
- DOLE Ireland
- Employees
- CDTX 73
- DOLE N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- DOLE Farming/Seeds/Milling
- Sector
- CDTX Health Care
- DOLE Consumer Staples
- Exchange
- CDTX Nasdaq
- DOLE Nasdaq
- Market Cap
- CDTX 1.6B
- DOLE 1.4B
- IPO Year
- CDTX 2015
- DOLE 2021
- Fundamental
- Price
- CDTX $65.32
- DOLE $13.76
- Analyst Decision
- CDTX Strong Buy
- DOLE
- Analyst Count
- CDTX 11
- DOLE 0
- Target Price
- CDTX $57.00
- DOLE N/A
- AVG Volume (30 Days)
- CDTX 489.9K
- DOLE 1.4M
- Earning Date
- CDTX 11-06-2025
- DOLE 08-11-2025
- Dividend Yield
- CDTX N/A
- DOLE 2.43%
- EPS Growth
- CDTX N/A
- DOLE N/A
- EPS
- CDTX N/A
- DOLE 0.25
- Revenue
- CDTX N/A
- DOLE $8,757,709,000.00
- Revenue This Year
- CDTX N/A
- DOLE $6.98
- Revenue Next Year
- CDTX N/A
- DOLE $1.91
- P/E Ratio
- CDTX N/A
- DOLE $54.97
- Revenue Growth
- CDTX N/A
- DOLE 4.75
- 52 Week Low
- CDTX $10.14
- DOLE $12.20
- 52 Week High
- CDTX $69.36
- DOLE $17.12
- Technical
- Relative Strength Index (RSI)
- CDTX 58.07
- DOLE 45.04
- Support Level
- CDTX $61.10
- DOLE $13.44
- Resistance Level
- CDTX $65.84
- DOLE $14.00
- Average True Range (ATR)
- CDTX 3.05
- DOLE 0.30
- MACD
- CDTX -0.42
- DOLE -0.08
- Stochastic Oscillator
- CDTX 71.23
- DOLE 34.46
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About DOLE Dole plc
Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace.